Wall Street brokerages predict that HealthStream, Inc. (NASDAQ:HSTM) will announce $62.37 million in sales for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for HealthStream’s earnings. The highest sales estimate is $63.92 million and the lowest is $61.10 million. HealthStream posted sales of $58.74 million in the same quarter last year, which suggests a positive year-over-year growth rate of 6.2%. The firm is scheduled to report its next earnings report on Tuesday, February 20th.

According to Zacks, analysts expect that HealthStream will report full-year sales of $62.37 million for the current fiscal year, with estimates ranging from $246.00 million to $248.15 million. For the next year, analysts anticipate that the firm will report sales of $268.72 million per share, with estimates ranging from $263.56 million to $272.62 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that follow HealthStream.

HealthStream (NASDAQ:HSTM) last issued its earnings results on Monday, October 23rd. The technology company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.03. HealthStream had a return on equity of 2.46% and a net margin of 2.36%. The business had revenue of $63.60 million for the quarter, compared to analyst estimates of $62.48 million. During the same quarter last year, the company earned $0.04 EPS. The business’s quarterly revenue was up 8.9% on a year-over-year basis.

Several brokerages have recently weighed in on HSTM. Zacks Investment Research lowered HealthStream from a “hold” rating to a “sell” rating in a research report on Wednesday, January 3rd. Needham & Company LLC reaffirmed a “hold” rating and set a $26.00 price target on shares of HealthStream in a research report on Tuesday, October 24th. Canaccord Genuity reaffirmed a “hold” rating and set a $25.00 price target on shares of HealthStream in a research report on Monday, October 23rd. ValuEngine raised HealthStream from a “sell” rating to a “hold” rating in a research report on Wednesday, January 3rd. Finally, Robert W. Baird cut their price target on HealthStream from $30.00 to $28.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 25th. One analyst has rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. HealthStream presently has an average rating of “Hold” and an average target price of $24.83.

Several hedge funds have recently made changes to their positions in HSTM. Janus Henderson Group PLC purchased a new position in shares of HealthStream in the 2nd quarter valued at approximately $23,186,000. Emerald Mutual Fund Advisers Trust purchased a new position in shares of HealthStream in the 3rd quarter valued at approximately $5,643,000. Conestoga Capital Advisors LLC grew its stake in shares of HealthStream by 14.3% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 1,497,650 shares of the technology company’s stock valued at $35,000,000 after purchasing an additional 186,948 shares during the last quarter. FMR LLC grew its stake in shares of HealthStream by 2.5% in the 2nd quarter. FMR LLC now owns 4,733,510 shares of the technology company’s stock valued at $124,586,000 after purchasing an additional 116,309 shares during the last quarter. Finally, Vanguard Group Inc. grew its stake in shares of HealthStream by 4.0% in the 2nd quarter. Vanguard Group Inc. now owns 2,324,958 shares of the technology company’s stock valued at $61,193,000 after purchasing an additional 89,220 shares during the last quarter. Institutional investors own 74.32% of the company’s stock.

Shares of HealthStream (NASDAQ HSTM) opened at $23.43 on Thursday. HealthStream has a 12-month low of $20.60 and a 12-month high of $31.53. The firm has a market capitalization of $751.16, a PE ratio of 130.17, a PEG ratio of 4.99 and a beta of 0.91.

TRADEMARK VIOLATION NOTICE: “$62.37 Million in Sales Expected for HealthStream, Inc. (HSTM) This Quarter” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.americanbankingnews.com/2018/01/11/62-37-million-in-sales-expected-for-healthstream-inc-hstm-this-quarter-2.html.

About HealthStream

HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.

Get a free copy of the Zacks research report on HealthStream (HSTM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.